Introduction
New therapeutic strategies attempt to amplify or restore the apoptotic death pathway by targeting the expression of pro-or antiapoptotic proteins (Solary et al., 2001) , whereas, previously, cancer therapies have usually involved nonselective agents that induce DNA damage or interfere with DNA repair. Shifting the balance to the proapoptotic pathway may increase apoptotic cell killing and represents a potential improvement in cancer therapy.
Several studies have attempted to overexpress the proapoptotic proteins involved in the formation of apoptosomes, such as Apaf-1 and caspase-9, which led to a clear increase in the radiosensitivity of U-373MG glioma cells (Shinoura et al., 2001) . Other approaches, like the overexpression of Bax (Lee et al., 1999; Lin et al., 2001) or p21 WAF1/CIP1 antisense oligonucleotides (Kokunai et al., 2001) , also enhanced radiation-induced apoptosis.
It has been proposed that ceramide is a proapoptotic lipidic messenger, involved in the response to various stimuli in a variety of normal and neoplastic cells (Perry, 1999; Kolesnick and Fuks, 2003) . In Jurkat leukaemia cells and SCC61 squamous carcinoma cells sensitive to anti-Fas and g-irradiation, we demonstrated that ceramide is a determining factor in the commitment phase of apoptosis (Rodriguez-Lafrasse et al., 2001; Alphonse et al., 2002) . Ceramide acts upstream from and conveys the apoptotic signal to the mitochondria, leading to the subsequent activation of executive caspases. In resistant SQ20B adenocarcinoma cells, the lack of ceramide generation in response to both anti-Fas and g-irradiation makes the whole pathway ineffective and leads to radioresistance .
Several works have also correlated defective ceramide generation or signalling with resistance to radiationinduced apoptosis (Chmura et al., 1997a, b; Bruno et al., 1998; Sautin et al., 2000) . Moreover, Selzner et al. (2001) demonstrated that ceramide levels are reduced by more than 50% in human colon tumours relative to those of healthy colon mucosa collected from the same patients. In a recent study, Riboni et al. (2002) demonstrated an inverse correlation between the malignant progression of human astrocytomas (low-and high-grade tumours) and the ceramide content measured in surgical specimens. They also found that low ceramide levels, which confer rapid growth and apoptotic-resistant features to tumours, were associated with low patient survival. That study thus supports the potential benefits of ceramidebased chemotherapy.
Therefore, manipulation of ceramide levels may be particularly relevant in the treatment of cancer (Radin, 2003) , and more specifically in amplifying the efficiency of radiotherapy. This was previously achieved either by the addition of short-chain or natural ceramide to tumour cells (Sautin et al., 2000; Lozano et al., 2001; Selzner et al., 2001 , Kimura et al., 2003 or by the addition of chemical agents that interfere with its metabolism in cell cultures or in xenografts in nude mice. For instance, Chmura et al. (1997a) reversed the radioresistance of the SQ20B tumour model in vitro and in vivo by increasing sphingomyelinase activity by the addition of chelerythrine. Raisova et al. (2002) increased the ceramide content and induced apoptosis in HaCaT keratinocytes and human melanoma cells by the addition of a ceramidase inhibitor.
We previously used a combination of three different inhibitors of sphingolipid metabolism, DL-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol. HCl (DL-PDMP) (a specific inhibitor of glucosylceramide synthase), D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol (D-MAPP) (an inhibitor of ceramidase), and imipramine (an amphiphilic amine that disturbs lipid turnover in biological membranes), to amplify the endogenous ceramide signal in lymphoid cell lines derived from leukaemic, Niemann-Pick A, or normal subjects . We demonstrated that endogenously formed ceramide triggers time-and concentration-dependent apoptotic cell death through the induction of mitochondrial injury and the activation of the caspase pathway. In this study, we take advantage of this pharmacological model to overcome the radioresistant phenotype of SQ20B squamous carcinoma cells. We studied the death response of this SQ20B cell line (SF2: 0.82) and also of SCC61 cells (SF2: 0.36), a radiosensitive control cell line derived from the same histological type, to the combined effects of 10-Gy irradiation and the combined poly-drug, DL-PDMP þ imipramine7D-MAPP. We present evidence for the usefulness of generating intracellular ceramide by a poly-association of inhibitors of sphingolipid metabolism to potentiate the cytotoxicity of radiotherapy in resistant tumours. This proceeds through the activation of both clonogenic and apoptotic death, which were not detectable in the response of SQ20B cells to irradiation only. Moreover, we demonstrate for the first time that, in SQ20B cells, the apoptotic death pathway is present but not functional in the absence of a certain threshold of ceramide generation. The enhancement of apoptotic death implies a marked increase in both mitochondrial dysfunction and caspase cleavage coupled to changes in redox status (reactive oxygen species (ROS) production and total glutathione depletion). Apoptotic cell death reached levels similar to those observed in radiosensitive SCC61 cells. Modulation of endogenous ceramide levels by the combined poly-drug (DL-PDMP þ imipramine7D-MAPP) may thus represent a new cellular target for the sensitization of radioresistant tumours to g-ray therapy.
Results
Similar enzymatic activities of neutral and acid sphingomyelinases, and glucosylceramide synthase in SQ20B and SCC61 cells in response to 10-Gy irradiation
We first verified that the lack of ceramide generation in radioresistant SQ20B cells does not result from enzymatic dysregulation. The activities of three enzymes implicated in the metabolism of ceramide were measured in SQ20B cells between 1 and 24 h after irradiation and compared with those of radiosensitive SCC61 cells. The total cellular content of sphingosine, glucosylceramide, and sialic acid were also determined in SQ20B cells.
The basal levels of neutral sphingomyelinase activity were very similar in the radioresistant and radiosensitive cell lines (Figure 1) . A dose of 10-Gy irradiation induced a gradual increase in neutral sphingomyelinase activity from 8 to 24 h in both cell lines (Po0.05). No significant activation of acid sphingomyelinase activity was observed between 1 and 24 h after irradiation in either cell line. Basal levels of this enzyme were 5.6470.44 mkat/mg protein in the radioresistant cell line, and threefold lower in the radiosensitive cell line. No significant variation in glucosylceramide synthase activity was observed after irradiation in either cell line. However, the basal level of this enzyme was higher in the radiosensitive SCC61 cells. Furthermore, the total cellular content of glucosylceramide, sphingosine (which reflects ceramidase activity), and sialic acid (which reflects cellular ganglioside content) did not differ between control and irradiated SQ20B cells (Figure 2 ).
Taken together, these results demonstrate that the lack of ceramide release in the radioresistant SQ20B cell line in response to 10-Gy irradiation did not result from a deficit in sphingomyelinase activity as measured under in vitro conditions, from highly stimulated glucosylceramide activity, or from rapid derivation to the sphingolipid pathway.
Radioresistance of SQ20B cells does not result from neutral sphingomyelinase inhibition by elevated glutathione levels
As basal glutathione levels were higher in resistant SQ20B cells than in SCC61 cells , we postulated that in SQ20B cells in vivo, neutral sphingomyelinase inhibition may be secondary to its inhibition by elevated glutathione levels (Liu and Hannun, 1997) . We therefore attempted to depress the cellular glutathione content with buthionine sulphoximine (BSO) treatment to overcome sphingomyelinase inhibition and to increase ceramide levels.
SQ20B cells were pretreated with 500 mM BSO 12 h before irradiation. As shown in Table 1 , treatment of control cells with BSO induced a significant decrease in total glutathione within 24 h (Po0.05) of the pretreatment. This decrease was associated with a burst of ROS production (Po0.05), a decrease in mitochondrial transmembrane potential (Dcm), and a subsequent increase in apoptosis. The combination of 10-Gy These experiments show that depleting the intracellular glutathione pool may induce apoptosis via the oxidative pathway, but does not influence ceramide release, suggesting a lack of neutral sphingomyelinase inhibition by elevated glutathione levels.
Overcoming resistance to clonogenic and apoptotic death by increasing endogenous ceramide levels in radioresistant SQ20B cells
As a 10-Gy irradiation did not trigger mitotic or apoptotic cell death in SQ20B cells, we tested whether the combination of DL-PDMP þ imipramine7D-MAPP with or without 10-Gy irradiation would increase endogenous ceramide levels and overcome resistance to cell death. Because kinetic studies have been previously validated in different cellular models Rodriguez-Lafrasse et al., 2002) , ceramide was quantified in SQ20B and SCC61 cells, 24 and 48 h after treatment. In order to determine the nature of cell death involved in response to ceramide generation, the mitotic cell death was quantified using clonogenic assay, and the apoptotic death was determined by flow cytometry using TUNEL labelling and cell cycle analysis. As expected , 10-Gy irradiation did not trigger any significant ceramide release in resistant SQ20B cells at either time (Figure 3) . The presence of DL-PDMP þ imipramine induced a 210712% increase in ceramide relative to control cells at 48 h (Po0.01). The combination of DL-PDMP þ imipramine with D-MAPP induced an even more pronounced elevation of ceramide, to a concentration of 4.570.7 nmol/pmol P (340723.7% of control cells; Po0.01) after 48 h. The combination of 10-Gy irradiation and chemical treatments induced an additional ceramide release producing a nearly cumulative pattern, with up to 6.171.1 nmol/pmol P of ceramide (405723% of controls; Po0.01) at 48 h. In comparison, The combination of irradiation and sphingolipid inhibitors induced a marked increase but no additive effect. Interestingly, ceramide levels seemed to reach a maximum of about 6.0 nmol/pmol P in both cell lines, in response to irradiation with chemical treatments.
The dose-response curves for SQ20B and SCC61 cells in response to g-irradiation with or without DL-PDMP þ imipramine7D-MAPP are presented in Figure 4 . They clearly show that SQ20B cells are much more resistant to g-irradiation (SF2: 0.82) than SCC61 cells (SF2: 0.36). The pretreatment of SQ20B cells with DL-PDMP þ imipramine before irradiation resulted in increased cytotoxicity at all radiation doses. The profile of the survival curve was similar to that for the radiosensitive SCC61 cells (SF2 of 0.33 for SQ20B cells treated with DL-PDMP þ imipramine versus 0.36 for SCC61). Combining the poly-drug (DL-PDMP þ imipramine þ D-MAPP) with irradiation led to a further decrease in the percentage of surviving cells (SF2: 0.18). Interestingly, the combination of DL-PDMP þ imipramine with irradiation did not cause more significant cytotoxic effects in SCC61 cells (SF2: 0.19).
The relative contribution of apoptosis to ceramideinduced cell death was then examined ( Figure 5 ). Exposure of SQ20B cells to 10-Gy irradiation did not induce significant apoptosis at 24 or 48 h, whereas girradiation of SCC61 cells led to a 280% increase in apoptotic cells at 48 h, relative to control cells (Po0.01). The addition of DL-PDMP þ imipramine or DL-PDMP þ imipramine þ D-MAPP to SQ20B cells for 48 h increased the percentage of TUNEL-positive cells by 37.676.8% (Po0.01) and 66.071.1% (Po0.01) of the total population, respectively. The triple poly-drug provoked an apoptotic cell death rate of 72.275.4% (Po0.01) in the SCC61 cell line at 48 h. Poly-drug treatment combined with irradiation increased the number of apoptotic cells to 87.375.7% at 48 h for SQ20B cells and 86.672.1% for SCC61 cells. Interestingly, changes in ceramide and apoptosis levels were directly correlated insofar as they reached approximately the same rate in both cell lines. Because the apoptotic cell rate should be estimated by another independent technique, quantification of the sub-G1 peak after propidium iodide labelling was used to confirm the results. The percentage of cells in sub-G1 was greatly increased in both cell lines treated with DL-PDMP þ imipramine7D-MAPP with or without irradiation at both times. Despite differences in the sensitivity of the two methods, both revealed the potentiation of radiation-induced apoptosis by combined DL-PDMP þ imipramine7D-MAPP in SCC61 and SQ20B cells.
These results demonstrate firstly that the apoptotic machinery is present in SQ20B multiresistant cells and that increasing endogenous ceramide levels with the poly-drug restored the defective pathway. Secondly, they clearly prove that ceramide elevation can overcome resistance to g-radiation and apoptosis.
Mitochondrial propagation of the death signal is initiated by endogenous ceramide
To date, two conflicting hypotheses have been proposed concerning the apoptotic death transduction pathway. The first implicates both mitochondrial alteration and caspase cleavage, whereas the second argues that the death signal is independent of the mitochondria and only involves caspase activation (Scaffidi et al., 1998) . To determine whether the ceramide pool liberated by poly-drug treatment induced apoptosis via a Figure 4 Clonogenic cell death assays performed on SQ20B and SCC61 cell lines treated or not with 20 mM DL-PDMP (P) þ 20 mM imipramine (I)75 mM D-MAPP (M). Cells were preincubated with DL-PDMP þ imipramine7D-MAPP for 30 min and irradiated at 0.5, 1, 2, 3, or 5 Gy. Drugs were removed after 24 h by changing the culture medium. The surviving fraction after each treatment was normalized to the surviving fraction in the corresponding control (plating efficiency) and survival curves were fitted using the linear quadratic model. Each value represents the mean of one experiment performed in triplicate Overcoming radioresistance by ceramide generation G Alphonse et al mitochondrial-dependent or -independent pathway, we explored the involvement of this organelle.
Because a decrease in Dc m only reflects mitochondrial membrane dysfunction, ROS production and total glutathione depletion were studied to clarify the intracellular redox status of the cell.
As previously published, 10-Gy irradiation does not induce significant variation in Dc m in SQ20B cells (Figure 6a ), in contrast to SCC61 cells, of which up to 71.4711.4% of cells had a high Dc m 48 h after irradiation. Moreover, the poly-drug provoked a significant decrease in Dc m in SQ20B cells, in that only 65.872.8% of cells exhibited high Dc m at 48 h compared with 97.371.4% of control cells (Po0.01). By comparison, under the same experimental conditions, only 50.174.4% of SCC61 cells exhibited high Dc m . Moreover, as previously observed for apoptotic status, the addition of 10-Gy radiation to treatment with DL-PDMP þ imipramine7D-MAPP resulted in a cumulative effect that increased the number of cells with high Dc m to 1.676.7% in the radioresistant cell line and to 50.174.4% in the radiosensitive cells.
As shown in Figure 6b , ceramide accumulation was associated with a significant drop in total glutathione. In the SQ20B cell line, 10-Gy irradiation induced no change in intracellular glutathione content, whereas intracellular glutathione decreased to 44% at 48 h in SCC61 cells. Incubation of both cell lines with DL-PDMP þ imipramine þ D-MAPP induced a decrease in intracellular glutathione, which reached 50% at 48 h (Po0.01) for SQ20B cells and 63% (Po0.01) for SCC61 cells. The combination of poly-drug treatment and irradiation caused no further decrease in glutathione levels. Interestingly, the basal level of total glutathione was twofold higher in SQ20B cells than in SCC61 cells, suggesting that radioresistant cells are more protected from oxidative stress than radiosensitive cells. In parallel with the decrease in glutathione, after 48 h of DL-PDMP þ imipramine þ D-MAPP treatment, a massive production of intracellular ROS (Figure 6c ) occurred in 2971% (Po0.01) of SQ20B cells and 42.570.4% (Po0.01) of SCC61 cells. Combining polydrug treatment with 10-Gy radiation induced an even more pronounced production of intracellular ROS in the two cell lines, as expected.
We here present evidence that the mitochondrial apoptotic machinery can be activated in a radioresistant cell line when a significant endogenous ceramide signal is generated.
Caspase activation by the elevation of endogenous ceramide
We first demonstrated that the transduction of the death signal, activated by endogenous ceramide in radioresistant cells, involved the mitochondria. We then investigated the role of caspase activation in the effective phase of apoptosis. Global quantification of caspase cleavage was first studied using flow cytometry. Immunoblotting was then used to determine more precisely the involvement of caspase-8 and caspase-3. In SQ20B cells (Figure 7 ), significant caspase activation occurred 24 h after poly-drug treatment (Po0.01) and increased to 694% of control cell levels at 48 h (Po0.01). The percentage of caspase activation increased to about the level observed in SCC61 cells. Consistent with this increase in ceramide, caspase activation was potentiated in both cell lines when irradiation was combined with drug treatment.
The proteolytic cleavage of pro-caspase-8 (Figure 8 , upper panel) and pro-caspase-3 (Figure 8 , middle panel) was followed by immunoblotting of the proteins from adherent and floating cells, separately. GAPDH (Figure 8 , lower panel) was used as a loading control to confirm changes in caspase-3 and caspase-8 levels in adherent SCC61 and SQ20B cells.
Expression of the p55 and p54 proforms of caspase-8 was detectable in adherent SQ20B cells at 24 and 48 h. A slight decrease in these proforms, without the appearance of cleavage products, was observed 48 h after DL-PDMP þ imipramine or DL-PDMP þ imipramine þ D-MAPP treatments combined with 10-Gy irradiation. The pro-and cleaved forms of caspase-8 were detectable in the floating population of treated cells, and associated 10-Gy irradiation caused the activation of this caspase. The proforms of both caspases did not vary at 24 h in adherent SCC61 cells, whereas at 48 h a decrease in the native forms was observed in treated and irradiated cells. The active p43/41 and p17 forms of caspase-8 and caspase-3, respectively, appeared weakly in the floating cells after 24 h of treatment, whereas a vast increase in these cleavage products was observed at 48 h.
The overall results of the study suggest that the ceramide released from irradiated SCC61 cells or from SQ20B cells treated with the poly-drug derives from a common metabolic pool.
Discussion
In the present work, we examined the combined effect of 10-Gy irradiation and a poly-drug treatment (20 mM DL-PDMP þ 20 mM imipramine75 mM D-MAPP) that enhances endogenous ceramide levels, in two head and neck squamous carcinoma cell lines (SQ20B and SCC61) with opposite radiosensitivities. Simultaneous exposure of SQ20B radioresistant cells to g-irradiation and polydrug treatment produced a synergistic response in terms of mitotic and apoptotic cell death. We demonstrated that increasing endogenous ceramide levels in these cells overcame apoptosis resistance by restoring the death signal transduction pathway, which had been ineffective following irradiation owing to a lack of ceramide generation . The enhancement of apoptosis implied a marked increase in both mitochondrial dysfunction and caspase cleavage. Interestingly, cell death reached levels similar to those observed in radiosensitive SCC61 cells. Moreover, these results suggest that the ceramide released by irradiation or poly-drug treatment converges upon common cellular targets at the level of the mitochondria and the caspase effector.
The p53 mutation is not a major determinant of SQ20B radioresistance because, as observed for most cancers, this protein was also mutated in the radiosensitive SCC61 cell line, which was derived from a tumour of the same histological type. On the contrary, the absence of the p53 apoptotic pathway strengthens the role of the p53-independent ceramide (Shi et al.,
2001) apoptotic pathway. The lack of ceramide signal in SQ20B cells could result from at least two enzymatic mechanisms, a deficiency in ceramide production or an ultrarapid detoxification caused by the metabolism of ceramide into intermediate compounds such as glucosylceramide or sphingosine derivatives. We previously established Rodriguez-Lafrasse et al., 2002) , in agreement with others (Chmura et al., 1997b; Pena et al., 2000; Jaffrezou et al., 2001) , that ceramide generation triggered in response to irradiation arises mainly from the sphingomyelinase-dependent catabolism of sphingomyelin. The loss of ceramide production, by neutral or acid sphingomyelinase deficiency, has previously been shown to confer resistance to g-irradiation (Santana et al., 1996; Chmura et al., 1997b; Michael et al., 1997; Bruno et al., 1998; Sautin et al., 2000) . Therefore, we compared the kinetic responses of neutral and acid sphingomyelinases in SQ20B and SCC61 cell lines. From this study, we can exclude a deficiency in these two enzymatic activities in resistant SQ20B cells. Furthermore, we have demonstrated, by depleting the intracellular glutathione pool with BSO, that the lack of ceramide release was not related to any in vivo inhibition of neutral sphingomyelinase by high glutathione concentrations. This result is in accordance with the report of El-Assaad et al. (2003), who demonstrated that glutathione supplementation or depletion did not alter radiation-induced ceramide accumulation in Molt-4 leukaemia cells.
A difference in glucosylceramide synthase activity in SQ20B resistant and SCC61 sensitive cells has never been demonstrated. However, increased activity might be expected because glucosylceramide synthesis is an important mechanism by which ceramide-induced apoptosis is averted. High cellular levels of glucosylceramide have been extensively correlated with multidrug resistance (Lavie et al., 1996; Lucci et al., 1998; Liu et al., 1999) . Modulation of glucosylceramide synthase activity by antisense transfection reversed resistance to adriamycin (Liu et al., 2000) , and overexpression of this enzyme significantly inhibited doxorubicin-induced apoptosis (Itoh et al., 2003) . However, some authors have challenged the involvement of glucosylceramide and glucosylceramide synthase in the phenomenon of multidrug resistance. Thus, Tepper et al. (2000) established that the overexpression of glucosylceramide synthase does not increase the resistance of cells to cytotoxic agents such as anti-Fas or etoposide. Furthermore, Veldman et al. (2003) demonstrated that both genetic and pharmacological alterations in cellular ceramide glycosylation capacity failed to sensitize melanoma cells to anticancer drugs such as doxorubicin. The synthesis of sphingosine-1-phosphate from ceramide catabolism has also been implicated in the radioresistance phenomenon, because it can act upon caspase activation by inhibiting the release of cytochrome c and Smac/DIABLO from the mitochondria into the cytosol (Cuvillier and ). We could not measure any significant difference in the kinetic study of free sphingosine, which is formed upstream of sphingosine-1-phosphate, or in glucosylceramide levels. These two Figure 7 Total caspase activation measured in response to the combined effect of 10-Gy irradiation and 20 mM DL-PDMP (P) þ 20 mM imipramine (I)75 mM D-MAPP (M). The two or three drugs were added to the medium 30 min before irradiation, and the cells were collected 24 or 48 h after treatment. Caspase activation was determined by flow cytometric analysis using the CaspACETM FITC-VAD-FMK In Situ Marker. Each value represents the mean7s.d. of two separate experiments performed in duplicate compounds were also detected during chromatographic ceramide quantification. Because all enzymatic activities were measured in vitro, we cannot exclude the possibility that the substrate was inaccessible to the enzyme in vivo. A worthy hypothesis for the absence of ceramide release in SQ20B cells may be a defect in the organization, number, or functionality of the membranous microdomains (Jacobson and Dietrich, 1999; Kurzchalia and Parton, 1999; Ramstedt and Slotte, 2002, Gulbins and because the neutral (Grazide et al., 2002) and acid sphingomyelinase activities of plasma membranes are preferentially localized in rafts (Mendez et al., 2001; Gulbins and Kolesnick, 2003) .
Amplification of endogenous ceramide by the inhibition of its metabolism was achieved in SQ20B and SCC61 cells treated with a combination of 20 mM DL-PDMP þ 20 mM imipramine75 mM D-MAPP. The advantage of combining several drugs that interfere with the endogenous ceramide pathway, rather than blocking one specific pathway (Raisova et al., 2002) or adding short-chain exogenous ceramide (Sugiki et al., 2000) , should be in reducing the concentration of potentially toxic chemical agents and blocking different metabolic routes only partially. The separate addition of these compounds did not generate ceramide release or apoptotic death in either cellular model, as previously described in lymphoid cell lines . Contrary to our findings, Bielawska et al. (1996) reported a threefold elevation in ceramide levels after the addition of 20 mM D-MAPP to HL60 cells. Moreover, Raisova et al. (2002) reported a twofold elevation in the death rate after 25 mM D-MAPP treatment of HaCaT keratinocytes. Recently, Choi et al. (2003) showed that treatment with D-MAPP induced an in vitro dose-dependent increase in apoptosis in mouse glomerular mesangial cells and an in vivo increase in the number of apoptotic cells on the mucosal surface of the duodenum in mice. DL-PDMP has also been shown to chemosensitize neuroblastoma cells to taxol and vincristine (Sietsma et al., 2000) and HepG2 hepatoma cells to doxorubicin (Di Bartolomeo and Spinedi, 2001 ). This agent is recognized as a glucosylceramide synthase inhibitor (Lavie et al., 1996) , but a direct effect on lysosomes cannot be excluded because, like imipramine, DL-PDMP may have lysosomotropic properties (Rosenwald and Pagano, 1994) . Recent studies report that damage of the lysosomal membrane and the consequent release of lysosomal contents into the cytosol may trigger apoptosis (Li et al., 2000) . Cathepsin D, a lysosomal protease, can either induce the cleavage of Bid, which leads to cytochrome c release and subsequent caspase activation (Stoka et al., 2001) , or trigger Bax activation, which induces the selective release of mitochondrial AIF (Bidere et al., 2003) . Imipramine could then act at the lysosomal level, but also through modification of the lipid raft structure and functions (Yokogawa et al., 2002) .
Of principal interest in this paper is the demonstration that increasing endogenous ceramide levels by inhibition of its metabolism clearly overcomes radioresistance. Because the mode of cell death (apoptotic versus mitotic) that determines cellular radiosensitivity is still unclear, both modes have been explored in this study. We have produced evidence that ceramide can induce cell killing by both mitotic and apoptotic mechanisms. It was previously reported that increasing intracellular ceramide levels, either by the inhibition of alkaline ceramidase or by the addition of exogenous C2-ceramide, can induce growth arrest in HL60 cells (Bielawska et al., 1996) and breast tumour cells (Gewirtz, 2000) , respectively. In most cases, this G1 arrest further led to mitotic death (McIlwrath et al., 1994) . We have demonstrated that, despite the absence of ceramide release, the apoptotic machinery is present in SQ20B cells and that it can be activated when the ceramide signal is restored. For the first time, we achieved a significant increase in ceramide levels in this cellular model, which was directly associated with the triggering of apoptosis. These results suggest that ceramide must reach a definite threshold level to trigger intracellular events but, on the other hand, cannot exceed an upper limit.
To date, the majority of studies based on radiosensitive cell lines have reported that radiation-induced apoptosis proceeds through changes in mitochondrial function and structure (Petit et al., 1997; Daniel, 2000) . We found evidence that the absence of mitochondrial dysfunction displayed in SQ20B cells after irradiation could be overcome by the generation of an endogenous ceramide signal. As a consequence of poly-drug treatment, ROS were generated in both cell lines, in agreement with Garcia-Ruiz et al. (1997) , who reported ROS production by isolated rat liver mitochondria in response to C2-ceramide. A significant decrease in glutathione has also been measured. Lavrentiadou et al. (2001) recently reported that the ROS-mediated depletion of glutathione plays a key role in ceramide generation by removing its inhibitory effect on neutral sphingomyelinase (Liu and Hannun, 1997; Liu et al., 1998) . Therefore, we propose an amplification loop in which glutathione depletion is triggered by the induction of ROS and this drop in glutathione activates ceramide formation by the activation of neutral sphingomyelinase. A sustained decrease in Dc m was also observed in response to the poly-drug treatment of SQ20B and SCC61 cells. Experiments conducted on different radiosensitive cell lines also confirm that exogenous (Decaudin et al., 1998; Ghafourifar et al., 1999) or endogenous ceramide (Tepper et al., 1999; Thomas et al., 1999; Rodriguez-Lafrasse et al., 2001; Alphonse et al., 2002) can directly trigger the loss of Dc m (Birbes et al., 2002) . The present work confirms that endogenous ceramide can induce apoptosis via a caspasedependent transduction pathway, in agreement with previous reports (Ito et al., 1999; Tepper et al., 1999; Thomas et al., 1999; Alphonse et al., 2002) . It also demonstrates that the cascade of caspases, inactivated in SQ20B cells in response to irradiation or anti-Fas, can be switched on following the generation of an intracellular ceramide signal. Finally, it confirms our previous observation , which places caspase-8 activation downstream from ceramide accumulation in response to 10-Gy irradiation.
The experiments equally suggest that the endogenous ceramide generated by poly-drug treatment of SQ20B or SCC61 cells derives from the same intracellular pool as the ceramide generated in the SCC61 cell line in response to 10-Gy irradiation, because no difference could be demonstrated in the kinetics or mechanisms of the responses.
Overall, we conclude from our experimental data that the modulation of endogenous ceramide levels may represent a new cellular target for the sensitization of radioresistant tumours to g-irradiation therapy.
Materials and methods

Chemical and biological reagents
DL-PDMP and D-MAPP were obtained from Biomol Research Laboratories Inc. (Plymouth Meeting, USA); BSO and imipramine from Sigma (St Louis, MO, USA) Ceramide (type III) from bovine brain sphingomyelin and free sphingoid bases used for calibration curves were purchased from Sigma. 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazolylcarbocyanine iodide (JC-1) was purchased from Molecular Probes (Leiden, The Netherlands) and CaspACEt FITC-VAD-FMK from Promega (Charbonnie`res, France). Anti-caspase-8 monoclonal antibody was supplied by Euromedex (Mundolsheim, France), anti-caspase-3 polyclonal antibody by R&D Systems (Abingdon, UK), and anti-GAPDH monoclonal antibody by Biodesign International (Saco, Maine, USA). The secondary antibodies used for caspase-8, GAPDH and caspase-3 immunoblots were, respectively, horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (Santa Cruz Biotechnology, Santa Cruz, USA), and HRP-conjugated rabbit antigoat IgG (Zymed, San Francisco, CA, USA). All other chemical reagents were of analytical grade.
Cell culture SCC61 and SQ20B cell lines derived from human head and neck squamous carcinomas were kindly provided by Dr J Bourhis (Institut Gustave Roussy, Villejuif, France) and Dr V Favaudon (Institut Curie, Orsay, France), respectively. Cells were grown in Dulbecco's modified Eagle's medium (DMEM) and Glutamax-I (0.86 mg/ml) supplemented with 10% (v/v) heat-inactivated foetal calf serum, 0.4 mg/ml hydrocortisone, 100U/ml penicillin, 100 mg/ml streptomycin, and 0.1% fungizone, and were maintained at 371C in a humidified atmosphere containing 5% CO 2 .
Irradiation and experimental procedures
At 16 h before treatment, cells were seeded in 25-cm 2 culture flasks at a density of 6.8 Â 10 4 cells/cm 2 for SQ20B and 6.8 Â 10 4 cells/cm 2 for SCC61. Cells were irradiated with a Saturne 42 irradiator, at a dose of 10 Gy delivered at a rate of 2.4 Gy/min. After incubation at 371C for 24 or 48 h, the cellular monolayer was scraped for the ceramide assay, lysed for Western blot analysis, or trypsinized for all other experiments. The cell pellet obtained by centrifugation was either frozen (ceramide, glutathione, and protein analyses), fixed (cell cycle analysis), or analysed immediately (ROS analysis and mitochondrial transmembrane potential measurement).
D-MAPP and DL-PDMP were stored in ethanol at À201C and used at final concentrations of 5 and 20 mM, respectively. Imipramine was stored frozen in water and used at a working concentration of 20 mM. DL-PDMP þ imipramine7D-MAPP was added directly to the culture medium and incubated for 24 or 48 h. When the inhibitors of sphingolipid metabolism were combined with irradiation, they were added to the culture medium 30 min before irradiation and maintained at those levels until the end of the experiment.
BSO was added to the SQ20B culture medium 12 h before irradiation at a final concentration of 500 mM.
Clonogenic cell death assay
Cell survival was assessed by a standard colony-formation assay. SQ20B and SCC61 cells were seeded in 25-cm 2 culture flasks at densities of 60-1500 and 180-1800 cells/cm 2 , respectively, to yield 10-200 colonies after irradiation with doses of 0.5, 1, 2, 3, or 5 Gy. DL-PDMP þ imipramine7D-MAPP was added to the culture medium 30 min before irradiation. The medium was changed 24 h after irradiation to remove the drugs. After 6 days at 371C, corresponding to six cellular divisions, the cells were washed with phosphate-buffered saline (PBS), fixed with methanol, and stained with Giemsa (Sigma). Colonies containing more than 50 cells were scored and the percentages of surviving cells were calculated. The surviving fraction after each treatment was normalized to the surviving fraction for the corresponding control (plating efficiency) and survival curves were fitted using the linear quadratic model.
Quantification of sialic acid
Cellular concentrations of sialic acid were determined by the resorcinol assay. Briefly, cells were lysed in water and total lipids were extracted in chloroform : methanol : water (5 : 5 : 1) for 24 h at 41C. After evaporation, lipid extracts were incubated for 20 min at 1001C in 400 ml of water and 400 ml of resorcinol mixture (resorcinol 0.3%, CuSO 4 0.25 mM, HCl 30%). The reaction was terminated by the addition of 0.8 ml of butanol : butyl acetate (15 : 85). After centrifugation at 2000 g for 3 min, the upper organic phases were analysed by spectrophotometry at 580 nm and quantified by comparison with a standard curve.
Enzymatic activities
Acid sphingomyelinase activity was measured in vitro as described by Vanier et al. (1980) . Briefly, cells were lysed in water and enzymatic activity was determined using 0.2 M sodium acetate buffer (pH 5) containing [choline-methyl- 14 C]-sphingomyelin (2.4 kBq/nmol; Amersham Pharmacia Biotech, Orsay, France) as substrate and 0.1% Triton X-100 as detergent.
Neutral sphingomyelinase activity was determined after cell fractionation of plasma membranes. The cells were lysed in 20 mM Tris (pH 7.2) buffer containing 0.1% Triton X-100 and antiprotease. After a first centrifugation at 1000 g, the pellet was discarded and the supernatant centrifuged for 1 h at 100 000 g. The second pellet containing the plasma membrane was then incubated for 2 h in 100 mM Tris (pH 7.4), 5 mM MgCl 2, 0.05% Triton X-100 containing [choline-methyl- 14 C]-sphingomyelin.
Glucosylceramide synthase activity was measured as described by Matsuo et al. (1992) . Briefly, about 100 mg of proteins was incubated for 30 min in a reaction mixture containing 50 mM 2-[N-morpholino]ethane-sulphonic acid (MES) buffer (pH 6.5), 5 mM MnCl 2 , 5 mM MgCl 2 , 0.5% 3-([3-cholamidopropyl]dimethylammonio)-1-propanesulphonate (CHAPS), and 20 mM uridine diphosphate-[
14 C]glucose. The reaction was terminated by the addition of 1 ml chloroform : methanol (2 : 1). Extracted lipids were resolved by thin-layer chromatography (TLC) using migration in two mobile phases: the first was chloroform : methanol : water (60 : 35 : 8) for half the length of the plate, and the second was chloroform : methanol : water (65 : 25 : 4) to the end of the plate. After autoradiography, the amount of glucosylceramide synthesized was estimated by scraping the spots that co-migrated with the unlabelled standard and then counting the radioactivity.
HPLC analysis
Ceramide, glucosylceramide, and free sphingoid bases were quantified by high-performance liquid chromatography (HPLC) with fluorimetric detection, as previously described (Rodriguez-Lafrasse et al., 2001) . Briefly, total cellular lipid extracts were divided into three parts that were either hydrolysed for 1 h at 1001C with 1 M KOH in methanol (total sphingoid base content), or for 1.5 h at 371C in 0.1 M KOH in chloroform : methanol (2 : 1, v/v) (free sphingoid bases content). The long-chain bases present in those two aliquots were derivatized with o-phthalaldehyde, then separated and quantified by HPLC as described by Rodriguez-Lafrasse et al. (1994) . The third aliquot was used to determine the total lipidic phosphorus content by the method of Fiske and Subbarow (1925) .
Total and oxidized cellular glutathione was quantified from cellular extracts prepared as described by Neuschwander-Tetri and Roll (1989) . After derivatization with o-phthalaldehyde, glutathione was quantified after separation by HPLC with fluorimetric detection at 340-nm excitation and 420-nm emission (Rodriguez-Lafrasse et al., 2001) .
Flow cytometric analysis
The terminal transferase dUTP nick end-labelling (TUNEL) reaction was carried out by labelling cells with the in situ Cell Death Detection Kit (Roche, Meylan, France). Briefly, after collection of both adherent and floating cells by centrifugation, 1-2 Â 10 6 cells were washed twice with PBS containing 1% bovine serum albumin, and fixed for 1 h with 4% paraformaldehyde in PBS. After one wash in PBS, the cells were permeabilized with a mixture of 0.1% Triton and 0.1% sodium citrate for 2 min at 41C. After another wash, cells were labelled for 1 h at 371C in the dark with TUNEL reaction mixture containing dUTP-fluorescein isothiocyanate (FITC) and terminal deoxynucleotidyl transferase (TdT). After two final washes, the cells were resuspended and 10 000 events were analysed by flow cytometry.
The percentage of cells in sub-G1 phase in the course of the cell cycle was taken as an index of apoptosis. SCC61 (1.7 Â 10 6 cells) and SQ20B (1.5 Â 10 6 cells) cells were pelleted and fixed in ice-cold 70% ethanol for at least 24 h. The cells (adherent and floating together) were then washed with PBS and incubated for 15 min in the dark at room temperature in 0.25 ml PBS, 0.25 ml RNase (1 mg/ml), and 0.5 ml propidium iodide (0.5 mg/ml). Analysis was performed on a Coulter Epix s flow cytometer.
Mitochondrial transmembrane potential (Dc m ) was measured with the lipophilic cation JC-1 probe, which selectively enters into mitochondria. After drug treatment and/or irradiation, cells were collected by trypsination and incubated with 5 mg/ml JC-1 for 20 min at 371C. Green fluorescence corresponding to monomer formation in the dye was immediately analysed by flow cytometry.
Intracellular ROS content was also measured in living cells, with the fluorescent probe dihydroethidium (HE), which permeates the cell membrane and can be oxidized into red fluorescent ethidium (Eth) in the presence of the superoxide anion. Cells were incubated with 4 mM HE for 20 min at 371C in the dark and analysed by flow cytometry with an FL-2 filter.
Caspase activation was determined using the CaspACEt FITC-VAD-FMK In Situ Marker. After chemical and/or physical treatments, cells were collected by trypsination and incubated at 371C in the dark with 10 mM FITC-VAD-FMK. After 20 min, a minimum of 10 000 events were analysed by flow cytometry to determine caspase activation.
Western blot analysis of caspase-8, caspase-3, and GAPDH For the analysis of caspase-8, caspase-3, and GAPDH, cell lysates were prepared as previously described . Briefly, the extracted proteins were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) on 12% (caspase 8) or 14% (caspase 3) polyacrylamide gels, and then transferred onto nitrocellulose membrane. Nonspecific binding was blocked for 1 h at room temperature with PBS, 0.05% Tween, 3% non-fat milk (PBSTM) for caspase 8 or with Tris-buffered saline (TBS), 0.05% Tween, 5% non-fat milk (TBSTM) for caspase 3 analysis. After overnight incubation at 41C with the primary antibodies (anticaspase-8 antibody was diluted to 1 : 1000 in PBSTM; anticaspase 3 to 1 : 2000 in TBST, 2% non-fat milk), the membranes were washed and incubated for 1 h with peroxidase-conjugated secondary antibodies at a dilution of 1 : 7500 for caspase 8 and 1 : 2000 for caspase 3. After the final washes, proteins were visualized with chemiluminescence reagents and exposed to Hyperfilm. Analysis of GAPDH was performed in parallel using an anti-GAPDH antibody at a dilution of 1 : 15 000 and a secondary antibody at a dilution of 1 : 7500.
Statistical analysis
Numerical data are expressed as means7s.d. The statistical significance of differences between the values calculated for different experimental treatments was determined with Student's t-test at Po0.05.
